Thorax

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
[Advanced]

The most recent version of this article was published on 1 February 2008

Thorax. Published Online First: 3 August 2007. doi:10.1136/thx.2007.077784
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society

This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
thx.2007.077784v1
63/2/129    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Add article to my folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gustafsson, P. M
Right arrow Articles by Lindblad, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gustafsson, P. M
Right arrow Articles by Lindblad, A.
Topic Collections
Right arrowRelated Article

Papers

Multiple-Breath Inert Gas Washout And Spirometry Vs. Structural Lung Disease In Cystic Fibrosis

Per M Gustafsson 1*, Pim A de Jong 2, Harm AWM Tiddens 2 and Anders Lindblad 3

1 Queen Silvia Children's Hospital, Göteborg, Sweden
2 Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, Netherlands
3 Queen Silvia Children's Hospital, Göteborg, Sudan

* To whom correspondence should be addressed. E-mail: per.gustafsson{at}vgregion.se.

Accepted 19 July 2007


*   Abstract

A sensitive and valid non-invasive marker of early cystic fibrosis (CF) lung disease is sought. The lung clearance index (LCI) from multiple-breath washout (MBW) is known to detect abnormal lung function more readily than spirometry in children and teenagers with CF, but its relationship to structural lung abnormalities is unknown.

OBJECTIVES: To determine the agreements between LCI and spirometry, respectively, with structural lung disease as measured by high-resolution computed tomography (HRCT) in children and teenagers with CF.

METHODS: This is a retrospective study of 44 consecutive CF patients aged 5-19 yrs (mean 12 yrs). At an annual check-up inspiratory and expiratory HRCT scans, LCI and spirometry (FEV1 and FEF75) were recorded. Abnormal structure was defined as a composite HRCT score >5 per cent, the presence of bronchiectasis, or air trapping >30 per cent. Abnormal lung function was defined as LCI above the predicted mean +1.96 residual standard deviations (RSD), or FEV1 or FEF75 below the predicted mean -1.96 RSD. Sensitivity /specificity assessments and correlation analyses were done.

RESULTS: The sensitivity to detect abnormal lung structure ranged from 85-94% for LCI, 19-26% for FEV1, and 62-75% for FEF75. Specificity ranged from 43-65% for LCI, 89 100% for FEV1, and 75-88% for FEF75. LCI correlated better with HRCT scores (Rs +0.85) than FEV1 (-0.62) or FEF75 (-0.66).

CONCLUSIONS: LCI is a more sensitive indicator than FEV1 or FEF75 for detecting structural lung disease in CF, and a normal LCI almost excludes HRCT abnormalities. The findings of abnormal LCI in some patients with normal HRCT scans suggest that LCI may be even more sensitive than HRCT to lung involvement in CF.


Keywords: Cystic Fibrosis, High-Resolution CT, Lung Clearance Index, Spirometry, Ventilation inhomogeneity


Related Article

Lung clearance index in CF: a sensitive marker of lung disease severity
Jane C Davies, Steve Cunningham, Eric W F W Alton, and J A Innes
Thorax 2008 63: 96-97. [Extract] [Full Text] [PDF]



This article has been cited by other articles:


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Bush
Update in Pediatric Lung Disease 2007
Am. J. Respir. Crit. Care Med., April 1, 2008; 177(7): 686 - 695.
[Full Text] [PDF]


Home page
ThoraxHome page
J. C Davies, S. Cunningham, E. W F W Alton, and J A Innes
Lung clearance index in CF: a sensitive marker of lung disease severity
Thorax, February 1, 2008; 63(2): 96 - 97.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH REGISTER
Terms and conditions relating to subscriptions purchased online  ¦  Website terms and conditions  ¦  Privacy policy
Copyright © 2007 BMJ Publishing Group Ltd & British Thoracic Society